Dutta A, Gazi M, Uddin S
Heliyon. 2023; 9(3):e14386.
PMID: 36925514
PMC: 10011005.
DOI: 10.1016/j.heliyon.2023.e14386.
Abdelwhab E, Hafez H
Viruses. 2012; 4(11):3179-208.
PMID: 23202521
PMC: 3509689.
DOI: 10.3390/v4113179.
Schroeder C
Subcell Biochem. 2010; 51:77-108.
PMID: 20213541
PMC: 7176229.
DOI: 10.1007/978-90-481-8622-8_3.
Hu J, Fu R, Cross T
Biophys J. 2007; 93(1):276-83.
PMID: 17434944
PMC: 1914427.
DOI: 10.1529/biophysj.106.102103.
Schroeder C, Heider H, Moncke-Buchner E, Lin T
Eur Biophys J. 2004; 34(1):52-66.
PMID: 15221235
DOI: 10.1007/s00249-004-0424-1.
Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
McCright I, Tsunoda I, Libbey J, Fujinami R
J Neurovirol. 2002; 8(2):100-10.
PMID: 11935462
DOI: 10.1080/13550280290049561.
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
Takeda M, Pekosz A, Shuck K, Pinto L, Lamb R
J Virol. 2002; 76(3):1391-9.
PMID: 11773413
PMC: 135863.
DOI: 10.1128/jvi.76.3.1391-1399.2002.
Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C.
Teuber G, Berg T, Naumann U, Raedle J, Brinkmann S, Hopf U
J Viral Hepat. 2001; 8(4):276-83.
PMID: 11454179
PMC: 7166378.
DOI: 10.1046/j.1365-2893.2001.00297.x.
Amantadine inhibits RANTES production by influenzavirus-infected human bronchial epithelial cells.
Asai Y, Hashimoto S, Kujime K, Gon Y, Mizumura K, Shimizu K
Br J Pharmacol. 2001; 132(4):918-24.
PMID: 11181433
PMC: 1572616.
DOI: 10.1038/sj.bjp.0703870.
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.
Zeuzem S, Teuber G, Naumann U, Berg T, Raedle J, Hartmann S
Hepatology. 2000; 32(4 Pt 1):835-41.
PMID: 11003631
PMC: 7165866.
DOI: 10.1053/jhep.2000.17740.
Uncoating kinetics of hepatitis A virus virions and provirions.
Bishop N, Anderson D
J Virol. 2000; 74(7):3423-6.
PMID: 10708462
PMC: 111846.
DOI: 10.1128/jvi.74.7.3423-3426.2000.
Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins.
Bui M, Whittaker G, Helenius A
J Virol. 1996; 70(12):8391-401.
PMID: 8970960
PMC: 190928.
DOI: 10.1128/JVI.70.12.8391-8401.1996.
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.
Ohuchi M, Cramer A, Vey M, Ohuchi R, Garten W, Klenk H
J Virol. 1994; 68(2):920-6.
PMID: 8289394
PMC: 236529.
DOI: 10.1128/JVI.68.2.920-926.1994.
Viruses as model systems in cell biology.
Compans R, Roberts P
Methods Cell Biol. 1994; 43 Pt A:3-42.
PMID: 7823868
PMC: 7130218.
DOI: 10.1016/s0091-679x(08)60596-8.
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
Wang C, Takeuchi K, Pinto L, Lamb R
J Virol. 1993; 67(9):5585-94.
PMID: 7688826
PMC: 237962.
DOI: 10.1128/JVI.67.9.5585-5594.1993.
Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport.
Takeuchi K, Lamb R
J Virol. 1994; 68(2):911-9.
PMID: 7507186
PMC: 236528.
DOI: 10.1128/JVI.68.2.911-919.1994.
Inhibition of dengue virus replication by amantadine hydrochloride.
Koff W, Elm Jr J, Halstead S
Antimicrob Agents Chemother. 1980; 18(1):125-9.
PMID: 7416739
PMC: 283951.
DOI: 10.1128/AAC.18.1.125.
Infectious entry pathway of influenza virus in a canine kidney cell line.
Matlin K, Reggio H, Helenius A, Simons K
J Cell Biol. 1981; 91(3 Pt 1):601-13.
PMID: 7328111
PMC: 2112819.
DOI: 10.1083/jcb.91.3.601.
Infectious cell entry mechanism of influenza virus.
Yoshimura A, Kuroda K, Kawasaki K, Yamashina S, Maeda T, Ohnishi S
J Virol. 1982; 43(1):284-93.
PMID: 7109028
PMC: 256119.
DOI: 10.1128/JVI.43.1.284-293.1982.
Antiviral agents: an update--Part I.
Ogra P
Indian J Pediatr. 1980; 47(388):431-40.
PMID: 7014434
DOI: 10.1007/BF02759848.
